← Leaderboards
Marianne Berwick
Sloan-Kettering Institute For Cancer Res
$13,901,848
Attributed
$15,663,542
Total exposure
17
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$25,742,176 · 18
By mechanism
P01$12,111,661 · 8
R01$6,757,582 · 4
U01$5,205,359 · 1
P30$831,447 · 2
K05$794,862 · 1
M01$41,265 · 2
Top collaborators
- Nancy E Thomas11 shared
- Jennifer L Hay3 shared
- Hoda A. Anton-Culver1 shared
- Colin B Begg1 shared
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Michael J Morris$6,941,101
- Lawrence H Schwartz$9,739,750
- Jennifer L Hay$5,633,773
- Nikola P Pavletich$5,261,204
- Scott Keeney$13,639,540
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaProgramsTumorResearch PersonnelGeneticEpidemiologyBaseAmerican Joint Committee On CancerDiagnosisCharacteristicsMelanoma BiomarkersMalignant NeoplasmsFollow-UpCollaborationsCohortMutationSkin CancerClinical BiomarkersMolecular MarkerEpigenetic ProcessBiological MarkersMethylationAdjuvant TherapyFunding
Grant awards (75)
Integration of Clinical and Molecular Biomarkers for Melanoma Survival$598,220
P01 · FY2022 · CA · contact PI
Integration of Clinical and Molecular Biomarkers for Melanoma Survival$1,987,168
P01 · FY2021 · CA · contact PI
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes$328,084
P01 · FY2021 · CA · contact PI
CORE 1: Administrative$112,686
P01 · FY2021 · CA · contact PI
Integration of Clinical and Molecular Biomarkers for Melanoma Survival$112,686
P01 · FY2021 · CA · contact PI
CORE 1: Administrative$67,738
P01 · FY2021 · CA · contact PI
Program Integration and Management$28,760
P01 · FY2021 · CA · contact PI
Identification of Lethal Melanomas at the Time of Diagnosis$972,565
R01 · FY2020 · CA
Integration of Clinical and Molecular Biomarkers for Melanoma Survival$536,127
P01 · FY2020 · CA · contact PI
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes$96,699
P01 · FY2020 · CA · contact PI
Sex Differences in Methylome Alterations and Mutational Burden in Early Stage Melanoma$95,969
P01 · FY2020 · CA · contact PI
CORE 1: Administrative$22,144
P01 · FY2020 · CA · contact PI
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes$11,997
P01 · FY2020 · CA · contact PI
Program Integration and Management$11,996
P01 · FY2020 · CA · contact PI
CORE 1: Administrative$11,996
P01 · FY2020 · CA · contact PI
Program Integration and Management$7,907
P01 · FY2020 · CA · contact PI
Integration of Clinical and Molecular Biomarkers for Melanoma Survival$1,944,358
P01 · FY2019 · CA · contact PI
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes$288,413
P01 · FY2019 · CA · contact PI
Integration of Clinical and Molecular Biomarkers for Melanoma Survival$74,384
P01 · FY2019 · CA · contact PI
CORE 1: Administrative$62,493
P01 · FY2019 · CA · contact PI
Program Integration and Management$22,267
P01 · FY2019 · CA · contact PI
Program Integration and Management$9,299
P01 · FY2019 · CA · contact PI
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes$9,299
P01 · FY2019 · CA · contact PI
CORE 1: Administrative$9,297
P01 · FY2019 · CA · contact PI
Integration of Clinical and Molecular Biomarkers for Melanoma Survival$2,361,160
P01 · FY2018 · CA · contact PI
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes$300,709
P01 · FY2018 · CA · contact PI
Genomic Evaluation of the Female Survival Advantages in Melanoma$75,897
P01 · FY2018 · CA · contact PI
CORE 1: Administrative$71,454
P01 · FY2018 · CA · contact PI
Program Integration and Management$22,955
P01 · FY2018 · CA · contact PI
Integration of Clinical and Molecular Biomarkers for Melanoma Survival$2,292,665
P01 · FY2017 · CA · contact PI
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes$423,859
P01 · FY2017 · CA · contact PI
CORE 1: Administrative$90,020
P01 · FY2017 · CA · contact PI
Program Integration and Management$22,955
P01 · FY2017 · CA · contact PI
Personalized Genomic Testing for Melanoma: Maximizing Personal Utility and Reach$657,031
R01 · FY2016 · CA
Personalized Genomic Testing for Melanoma: Maximizing Personal Utility and Reach$672,443
R01 · FY2015 · CA
Melanoma Prevention: Using the Sun$159,998
K05 · FY2015 · CA · contact PI
Personalized Genomic Testing for Melanoma: Maximizing Personal Utility and Reach$735,067
R01 · FY2014 · CA
Melanoma Prevention: Using the Sun$156,292
K05 · FY2014 · CA · contact PI
Cancer Population Sciences Research Program$73,031
P30 · FY2014 · CA · contact PI
Melanoma Prevention: Using the Sun$159,710
K05 · FY2013 · CA · contact PI
Cancer Population Sciences Research Program$70,488
P30 · FY2013 · CA · contact PI
Cancer Population Sciences Research Program$6,252
P30 · FY2013 · CA · contact PI
Melanoma Prevention: Using the Sun$156,185
K05 · FY2012 · CA · contact PI
Cancer Population Sciences Research Program$75,493
P30 · FY2012 · CA · contact PI
Cancer Population Sciences Research Program$7,778
P30 · FY2012 · CA · contact PI
Cancer Population Sciences Research Program$4,167
P30 · FY2012 · CA · contact PI
Melanoma Prevention: Using the Sun$162,677
K05 · FY2011 · CA · contact PI
Cancer Population Sciences Research Program$85,974
P30 · FY2011 · CA · contact PI
Cancer Population Sciences Research Program$96,865
P30 · FY2010 · CA · contact PI
RESPONSE OF SERUM 25-HYDROXYVITAMIN D TO INCIDENTAL UV LIGHT EXPOSURE$8,921
M01 · FY2010 · RR · contact PI
Solar Exposure and Melanoma Survival$413,130
R01 · FY2009 · CA · contact PI
Solar Exposure and Melanoma Survival$147,045
R01 · FY2009 · CA · contact PI
EPIDEMIOLOGY$93,334
P30 · FY2009 · CA · contact PI
Solar Exposure and Melanoma Survival$69,150
R01 · FY2009 · CA · contact PI
RESPONSE OF SERUM 25-HYDROXYVITAMIN D TO INCIDENTAL UV LIGHT EXPOSURE$32,344
M01 · FY2009 · RR · contact PI
Solar Exposure and Melanoma Survival$426,227
R01 · FY2008 · CA · contact PI
EPIDEMIOLOGY$92,754
P30 · FY2008 · CA · contact PI
Solar Exposure and Melanoma Survival$492,111
R01 · FY2007 · CA · contact PI
EPIDEMIOLOGY$93,607
P30 · FY2007 · CA · contact PI
Solar Exposure and Melanoma Survival$475,102
R01 · FY2006 · CA · contact PI
EPIDEMIOLOGY$65,852
P30 · FY2006 · CA · contact PI
Solar Exposure and Melanoma Survival$512,756
R01 · FY2005 · CA
The Risk of Cancer in Fanconi Anemia Heterozygotes$77,510
R01 · FY2005 · CA
EPIDEMIOLOGY$65,852
P30 · FY2005 · CA
The Risk of Cancer in Fanconi Anemia Heterozygotes$243,740
R01 · FY2004 · CA
The Risk of Cancer in Fanconi Anemia Heterozygotes$61,924
R01 · FY2004 · CA
A MODEL FOR GENETIC SUSCEPTIBILITY: MELANOMA$948,410
U01 · FY2003 · CA
The Risk of Cancer in Fanconi Anemia Heterozygotes$290,293
R01 · FY2003 · CA
A MODEL FOR GENETIC SUSCEPTIBILITY: MELANOMA$106,737
U01 · FY2003 · CA
A MODEL FOR GENETIC SUSCEPTIBILITY: MELANOMA$28,928
U01 · FY2003 · CA
A MODEL FOR GENETIC SUSCEPTIBILITY: MELANOMA$1,335,972
U01 · FY2002 · CA
The Risk of Cancer in Fanconi Anemia Heterozygotes$255,744
R01 · FY2002 · CA
A MODEL FOR GENETIC SUSCEPTIBILITY: MELANOMA$1,342,683
U01 · FY2001 · CA
The Risk of Cancer in Fanconi Anemia Heterozygotes$255,744
R01 · FY2001 · CA
A MODEL FOR GENETIC SUSCEPTIBILITY: MELANOMA$1,442,629
U01 · FY2000 · CA